about
Strengthening the research to policy and practice interface: exploring strategies used by research organisations working on sexual and reproductive health and HIV/AIDSBacterial vaginosis, vaginal flora patterns and vaginal hygiene practices in patients presenting with vaginal discharge syndrome in The Gambia, West AfricaNeisseria gonorrhoeae and Chlamydia trachomatis infection in HIV-1-infected women taking antiretroviral therapy: a prospective cohort study from Burkina FasoEpidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review.Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries.Episodic therapy for genital herpes in sub-saharan Africa: a pooled analysis from three randomized controlled trials.The cost of providing combined prevention and treatment services, including ART, to female sex workers in Burkina Faso.Genital warts and infection with human immunodeficiency virus in high-risk women in Burkina Faso: a longitudinal study.Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population.Antimicrobial susceptibility, auxotype and plasmid content of Neisseria gonorrhoeae in northern Tanzania: emergence of high level plasmid mediated tetracycline resistance.Non-detection of human herpesvirus 8 (HHV-8) DNA in HHV-8-seropositive blood donors from three Brazilian regions.Long-term virological, immunological and mortality outcomes in a cohort of HIV-infected female sex workers treated with highly active antiretroviral therapy in Africa.Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South AfricaReal-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV.Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial.Sexual and reproductive health among primary and secondary school pupils in Mwanza, Tanzania: need for intervention.Variations in human herpesvirus type 8 seroprevalence in Native Americans, South America.Cervicovaginal neutralizing antibodies to herpes simplex virus (HSV) in women seropositive for HSV Types 1 and 2.Using research to influence sexual and reproductive health practice and implementation in Sub-Saharan Africa: a case-study analysisGetting research into policy - Herpes simplex virus type-2 (HSV-2) treatment and HIV infection: international guidelines formulation and the case of Ghana.Investing in the future: lessons learnt from communicating the results of HSV/ HIV intervention trials in South AfricaPerformance of the BioPlex 2200 multiplexing immunoassay platform for the detection of herpes simplex virus type 2 specific antibodies in African settings.Factors associated with failure to screen for syphilis during antenatal care in Ghana: a case control study.High prevalence of trichomoniasis in rural men in Mwanza, Tanzania: results from a population based study.Operational performance of an STD control programme in Mwanza Region, Tanzania.The interrelation of HIV, cervical human papillomavirus, and neoplasia among antenatal clinic attenders in Tanzania.Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka.Bacterial vaginosis in relation to menstrual cycle, menstrual protection method, and sexual intercourse in rural Gambian women.Aetiology of sexually transmitted infections and response to syndromic treatment in southwest UgandaGenital human papillomavirus genotypes in northwestern Tanzania.HIV prevention and care services for female sex workers: efficacy of a targeted community-based intervention in Burkina Faso.Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies'It's not about money, it's about my health': determinants of participation and adherence among women in an HIV-HSV2 prevention trial in Johannesburg, South AfricaCosts of cervical cancer screening and treatment using visual inspection with acetic acid (VIA) and cryotherapy in Ghana: the importance of scale.Performance of Syphilis Sentinel Surveillance in the context of endemic Treponematoses: experience from Ghana.AIDS-related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa.Associations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa.Transmission of human herpesvirus type 8 infection within families in american indigenous populations from the Brazilian Amazon.Human herpesvirus-8 infection and oral shedding in Amerindian and non-Amerindian populations in the Brazilian Amazon regionHerpes Simplex Virus Type-2 Cervicovaginal Shedding Among Women Living With HIV-1 and Receiving Antiretroviral Therapy in Burkina Faso: An 8-Year Longitudinal Study.
P50
Q21245517-20DBE93B-5FEC-45A7-8AAA-F82275E7FE52Q24805415-953119CF-E636-48D6-A516-30DAC2FBBBD8Q28658697-54AEF27C-C1D6-4133-A336-9463C8849383Q30227546-3C5B8FEB-CE01-40F3-AAE8-84C2D289F926Q30230410-D1D7FD2F-ACFA-4F98-9ADF-714246446CD7Q31028568-C8A3EBA4-EE2B-4AF6-BF12-7B66923DEC16Q33783859-3D905794-7BD9-41EE-B829-FDA43E91125EQ33798628-BA350B33-6EB3-4997-83C2-64DE1C789F6BQ33835357-A522A26E-B8A2-42A1-A4F7-0549631E0239Q33935149-109C1C00-DFDC-4CBC-A75F-FC849B32B24BQ33999780-2F81F002-2158-423D-A2C2-9589A75EC830Q34019508-E899A55A-1EEB-42B0-9CCE-44EE5F63515AQ34168214-652A6AD1-79A2-4A5C-B68E-31D530E86160Q34430752-A4C7286E-D9D7-4C5E-8068-DC99271C4981Q34721145-C0F945F3-641A-47F8-A37A-CEF1236C8B26Q34755124-8989B841-AA0F-4C07-AECD-9BDEC41FD5BDQ34907933-EB21162B-A00C-4C98-9B7E-AE1A68E6D0CEQ34995949-C44E6ADB-D095-4EF4-A7D2-FFB34E412125Q35062445-54BF57A7-BBAC-4B33-8B03-B45330C81DCEQ35062477-266E5F67-1495-4213-871B-5BB672146505Q35062487-265C74C7-5A7C-4394-89C6-FE31FFD561F7Q35138634-490FDDDD-5419-494E-90E7-83FB89435307Q35191139-B0B5797B-3EE1-4A2A-AA0E-FEBE5FE366BBQ35528909-0F589578-2398-45C1-A89A-78D0B1DCC728Q35529110-94E9963F-10C7-4C9B-B05A-97F4631D3FA1Q35529476-952B9F55-1F15-4F39-937B-5C16CB5FA83EQ35530858-80FE0FEF-6111-4F49-A36C-A18A9EB39D1FQ35531743-F8A39F19-8287-49A2-858D-853BF56D8B8DQ35532012-D34FFAD6-9CD3-45BD-BC88-6EAE4E11ECAEQ35922918-485CFCBC-1C56-49DA-9254-90D3F842A022Q36064462-231B5E8C-1901-4DF7-8B66-B216E2562775Q36148666-3A16AD03-EA59-458E-8107-A19BE40FF608Q36194047-5396EF3A-9AB6-43E2-B1C6-1413DDA26EF6Q36195826-8FA8E8DF-266B-4EB7-BEBC-8E7683BF06B2Q36219085-19A4F64A-55BF-4818-A13F-F129406E06F6Q36268446-50E6065F-168D-44F5-B613-D4E647D39525Q36319807-C188FD75-1D18-4A87-8AA4-0912DF87CAFAQ36507059-A3955C49-0584-45DE-AAF7-60EBDB627CFCQ36529002-BDA6BB97-4E78-492A-A92D-A0CEEB660765Q36562841-073FE8F4-FC64-4997-BB80-E8C8190E3ADF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Philippe Mayaud
@ast
Philippe Mayaud
@en
Philippe Mayaud
@es
Philippe Mayaud
@nl
Philippe Mayaud
@sl
type
label
Philippe Mayaud
@ast
Philippe Mayaud
@en
Philippe Mayaud
@es
Philippe Mayaud
@nl
Philippe Mayaud
@sl
altLabel
Philippe MAYAUD
@en
prefLabel
Philippe Mayaud
@ast
Philippe Mayaud
@en
Philippe Mayaud
@es
Philippe Mayaud
@nl
Philippe Mayaud
@sl
P106
P21
P31
P496
0000-0001-5730-947X